Compare DexCom, Inc. (DXCM) vs Invesco S&P 500 High Div Low Volatility ETF (SPHD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
DexCom, Inc. vs Invesco S&P 500 High Div Low Volatility ETF — how do they compare? DexCom, Inc. trades at $77.95 (market cap $28.06B), while Invesco S&P 500 High Div Low Volatility ETF trades at $53.17. The key difference: Invesco S&P 500 High Div Low Volatility ETF is trading nearer its 52-week high, DexCom, Inc. nearer its low. Which is the better fit depends on your goals.
| DXCM | SPHD | |
|---|---|---|
Market Cap | $28.06B | — |
Sector | Health | — |
52-Week High | $89.53 | $52.63 |
52-Week Low | $54.84 | $46.96 |
Enterprise Value | $27.03B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
DXCM trades at $77.31, up 4.3% on the day, with a bullish technical outlook as it approaches resistance near $78. The company reported strong earnings beats in recent quarters, with Q1 2026 EPS of $0.56 surpassing expectations of $0.47. Revenue growth accelerated to $4.66 billion in 2025, while net income margin expanded to 17.93%. Recent regulatory approvals, including Health Canada authorization for the G7 15-day CGM, support continued international expansion.
The stock offers growth potential with analyst consensus price target of $84.33, though high valuation multiples (P/E 31.21) and competition in the CGM market present risks. Expansion into non-insulin Type 2 diabetes and pediatric markets could drive future revenue, but commercial uptake remains unproven. Institutional sentiment remains strongly bullish with 80% buy ratings.
The Invesco S&P 500 High Dividend Low Volatility ETF (SPHD) trades at $53.06, up 2.08% on the day, with a bullish technical signal from moving averages and neutral oscillators. The fund provides monthly dividend income with a 4.5% 30-day SEC yield, targeting high-dividend, low-volatility S&P 500 stocks. Recent news highlights its role in retirement income portfolios, though historical returns have lagged the broader S&P 500.
SPHD offers defensive income exposure suitable for risk-averse investors, with a portfolio tilted toward real estate, consumer staples, and financials. Key risks include underperformance during strong bull markets and concentration in value sectors. The fund's consistent monthly payout and low-volatility mandate provide stability, but growth-oriented investors may find total returns insufficient.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About DexCom, Inc.
Dexcom designs and commercializes continuous glucose monitoring systems for diabetics. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to include the disposable sensor and the durable receiver.
Read more on DXCM →About Invesco S&P 500 High Div Low Volatility ETF
The fund generally will invest at least 90% of its total assets in the securities that comprise the underlying index. Strictly in accordance with its guidelines and mandated procedures, S&P Dow Jones Indices LLC (the “index Provider”) compiles, maintains and calculates the underlying index, which is designed to measure the performance of 50 least volatile high yielding constituents of the S&P 500 ® Index in the past year.
Read more on SPHD →
